G8 Countries Pharmaceuticals Market Summary, Competitive Analysis and Forecast, 2018-2027
Summary
The G8 Pharmaceuticals industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value 2018-22, and forecast to 2027). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.
Key Highlights
The G8 countries contributed $774.7 billion in 2022 to the global pharmaceuticals industry, with a compound annual growth rate (CAGR) of 2.3% between 2018 and 2022. The G8 countries are expected to reach a value of $897.4 billion in 2027, with a CAGR of 3% over the 2022-27 period.
Among the G8 nations, the US is the leading country in the pharmaceuticals industry, with market revenues of $408.0 billion in 2022. This was followed by Japan and Germany, with a value of $92.3 and $83.2 billion, respectively.
The US is expected to lead the pharmaceuticals industry in the G8 nations with a value of $463.0 billion in 2016, followed by Germany and Japan with expected values of $107.9 and $106.5 billion, respectively.
Scope
Save time carrying out entry-level research by identifying the size, growth, and leading players in the G8 pharmaceuticals market
Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the G8 pharmaceuticals market
Leading company profiles reveal details of key pharmaceuticals market players’ G8 operations and financial performance
Add weight to presentations and pitches by understanding the future growth prospects of the G8 pharmaceuticals market with five year forecasts
Compares data from the US, Canada, Germany, France, UK, Italy, Russia and Japan, alongside individual chapters on each country
Reasons to Buy
What was the size of the G8 pharmaceuticals market by value in 2022?
What will be the size of the G8 pharmaceuticals market in 2027?
What factors are affecting the strength of competition in the G8 pharmaceuticals market?
How has the market performed over the last five years?
Who are the top competitors in the G8 pharmaceuticals market?
1 Introduction
1.1. What is this report about?
1.2. Who is the target reader?
1.3. How to use this report
1.4. Definitions
2 Group of Eight (G8) Pharmaceuticals
2.1. Industry Outlook
3 Pharmaceuticals in Canada
3.1. Market Overview
3.2. Market Data
3.3. Market Segmentation
3.4. Market outlook
3.5. Five forces analysis
4 Macroeconomic Indicators
4.1. Country data
5 Pharmaceuticals in France
5.1. Market Overview
5.2. Market Data
5.3. Market Segmentation
5.4. Market outlook
5.5. Five forces analysis
6 Macroeconomic Indicators
6.1. Country data
7 Pharmaceuticals in Germany
7.1. Market Overview
7.2. Market Data
7.3. Market Segmentation
7.4. Market outlook
7.5. Five forces analysis
8 Macroeconomic Indicators
8.1. Country data
9 Pharmaceuticals in Italy
9.1. Market Overview
9.2. Market Data
9.3. Market Segmentation
9.4. Market outlook
9.5. Five forces analysis
10 Macroeconomic Indicators
10.1. Country data
11 Pharmaceuticals in Japan
11.1. Market Overview
11.2. Market Data
11.3. Market Segmentation
11.4. Market outlook
11.5. Five forces analysis
12 Macroeconomic Indicators
12.1. Country data
13 Pharmaceuticals in Russia
13.1. Market Overview
13.2. Market Data
13.3. Market Segmentation
13.4. Market outlook
13.5. Five forces analysis
14 Macroeconomic Indicators
14.1. Country data
15 Pharmaceuticals in The United Kingdom
15.1. Market Overview
15.2. Market Data
15.3. Market Segmentation
15.4. Market outlook
15.5. Five forces analysis
16 Macroeconomic Indicators
16.1. Country data
17 Pharmaceuticals in The United States
17.1. Market Overview
17.2. Market Data
17.3. Market Segmentation
17.4. Market outlook
17.5. Five forces analysis
18 Macroeconomic Indicators
18.1. Country data
19 Company Profiles
19.1. Johnson & Johnson
19.2. Apotex, Inc.
19.3. Laboratoires Pierre Fabre SA
19.4. F. Hoffmann-La Roche Ltd
19.5. Boehringer Ingelheim GmbH
19.6. A Menarini Industrie Farmaceutiche Riunite Srl